A phase Ib/II study of modakafusp alfa alone and in combination with pembrolizumab in patients with advanced or metastatic solid tumors.
- DOI
- 10.3389/fonc.2025.1620987
- Published
- 2025
- Container
- Frontiers in oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fonc.2025.1620987,
title = {A phase Ib/II study of modakafusp alfa alone and in combination with pembrolizumab in patients with advanced or metastatic solid tumors.},
author = {Gill D and Cowey CL and Daniels GA and Sommerhalder D and Abdul-Karim R and Kirkwood JM and Kolodney J and Mehmi I and Roberts-Thomson R and Strauss J and Thomas S and Whitman E and Xing Y and McKean M and Collins S and Li C and Saggu G and Chen T and Wang S and Lewis M and Parot X and Johnson M},
year = {2025},
journal = {Frontiers in oncology},
doi = {10.3389/fonc.2025.1620987},
url = {https://doi.org/10.3389/fonc.2025.1620987}
}RIS
TY - JOUR TI - A phase Ib/II study of modakafusp alfa alone and in combination with pembrolizumab in patients with advanced or metastatic solid tumors. AU - Gill D AU - Cowey CL AU - Daniels GA AU - Sommerhalder D AU - Abdul-Karim R AU - Kirkwood JM AU - Kolodney J AU - Mehmi I AU - Roberts-Thomson R AU - Strauss J AU - Thomas S AU - Whitman E AU - Xing Y AU - McKean M AU - Collins S AU - Li C AU - Saggu G AU - Chen T AU - Wang S AU - Lewis M AU - Parot X AU - Johnson M PY - 2025 JO - Frontiers in oncology DO - 10.3389/fonc.2025.1620987 UR - https://doi.org/10.3389/fonc.2025.1620987 ER -
APA
D, G., CL, C., GA, D., D, S., R, A., JM, K., J, K., I, M., R, R., J, S., S, T., E, W., Y, X., M, M., S, C., C, L., G, S., T, C., S, W., M, L., X, P., & M, J. (2025). A phase Ib/II study of modakafusp alfa alone and in combination with pembrolizumab in patients with advanced or metastatic solid tumors.. Frontiers in oncology. https://doi.org/10.3389/fonc.2025.1620987
Source records
- pubmed · retrieved 2026-09-25T10:35:40.270Z